These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11389695)

  • 1. Transcriptional activities of p73 splicing variants are regulated by inter-variant association.
    Ueda Y; Hijikata M; Takagi S; Chiba T; Shimotohno K
    Biochem J; 2001 Jun; 356(Pt 3):859-66. PubMed ID: 11389695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function.
    Watanabe K; Ozaki T; Nakagawa T; Miyazaki K; Takahashi M; Hosoda M; Hayashi S; Todo S; Nakagawara A
    J Biol Chem; 2002 Apr; 277(17):15113-23. PubMed ID: 11844794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New p73 variants with altered C-terminal structures have varied transcriptional activities.
    Ueda Y; Hijikata M; Takagi S; Chiba T; Shimotohno K
    Oncogene; 1999 Sep; 18(35):4993-8. PubMed ID: 10490834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
    Racek T; Mise N; Li Z; Stoll A; Pützer BM
    J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73.
    Liu G; Chen X
    J Biol Chem; 2005 May; 280(20):20111-9. PubMed ID: 15769743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 protein variants: structural and functional similarities with p63 and p73 isoforms.
    Courtois S; Caron de Fromentel C; Hainaut P
    Oncogene; 2004 Jan; 23(3):631-8. PubMed ID: 14737098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
    Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
    J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
    Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
    Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity.
    Miyazaki K; Ozaki T; Kato C; Hanamoto T; Fujita T; Irino S; Watanabe K; Nakagawa T; Nakagawara A
    Biochem Biophys Res Commun; 2003 Aug; 308(1):106-13. PubMed ID: 12890487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation of cellular and viral promoters by p73 and p53.
    Deb D; Lanyi A; Scian M; Keiger J; Brown DR; Le Roith D; Deb SP; Deb S
    Int J Oncol; 2001 Feb; 18(2):401-9. PubMed ID: 11172610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
    Muttray AF; Cox RL; Reinisch CL; Baldwin SA
    Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduced p73alpha activates a minimal promoter through a mechanism independent of its transcriptional activity.
    Takagi S; Ueda Y; Hijikata M; Shimotohno K
    FEBS Lett; 2001 Nov; 509(1):47-52. PubMed ID: 11734204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.
    Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A
    Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCAF is a coactivator for p73-mediated transactivation.
    Zhao LY; Liu Y; Bertos NR; Yang XJ; Liao D
    Oncogene; 2003 Nov; 22(51):8316-29. PubMed ID: 14614455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of p73 functional domains necessary for transactivation and growth suppression.
    Nozell S; Wu Y; McNaughton K; Liu G; Willis A; Paik JC; Chen X
    Oncogene; 2003 Jul; 22(28):4333-47. PubMed ID: 12853970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DeltaNp73beta is active in transactivation and growth suppression.
    Liu G; Nozell S; Xiao H; Chen X
    Mol Cell Biol; 2004 Jan; 24(2):487-501. PubMed ID: 14701724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical role of p73 in neuroblastoma.
    Romani M; Tonini GP; Banelli B; Allemanni G; Mazzocco K; Scaruffi P; Boni L; Ponzoni M; Pagnan G; Raffaghello L; Ferrini S; Croce M; Casciano I
    Cancer Lett; 2003 Jul; 197(1-2):111-7. PubMed ID: 12880969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia.
    Novak U; Grob TJ; Baskaynak G; Peters UR; Aebi S; Zwahlen D; Tschan MP; Kreuzer KA; Leibundgut EO; Cajot JF; Tobler A; Fey MF
    Ann Oncol; 2001 Jul; 12(7):981-6. PubMed ID: 11521806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.